Literature DB >> 1662724

Antitumor agents. 120. New 4-substituted benzylamine and benzyl ether derivatives of 4'-O-demethylepipodophyllotoxin as potent inhibitors of human DNA topoisomerase II.

X M Zhou1, Z Q Wang, J Y Chang, H X Chen, Y C Cheng, K H Lee.   

Abstract

A number of new 4'-O-demethylepipodophyllotoxin derivatives possessing various 4 beta-N- or 4 beta-O-benzyl groups have been synthesized and evaluated for their inhibitory activity against the human DNA topoisomerase II as well as for their activity in causing cellular protein-linked DNA breakage. The 4 beta-N-benzyl derivatives 9-22 are, in general, as active or more active than etoposide (1). The most active compounds are 14, 16, and 17, which are more than 2-fold more potent than 1. The results indicated that a basic unsubstituted 4 beta-benzylamino moiety is structurally required for the enhanced activity. Replacement of the benzyl nitrogen with oxygen gave compounds (23 and 24) which are inactive. The ability of these compounds to inhibit human DNA topoisomerase II and to cause protein-linked DNA breakage appears to have no direct correlation with cytotoxicity in KB cells.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1662724     DOI: 10.1021/jm00116a001

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  11 in total

Review 1.  Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach.

Authors:  Kuo-Hsiung Lee
Journal:  J Nat Prod       Date:  2010-03-26       Impact factor: 4.050

2.  Design, synthesis, and cytotoxicity of perbutyrylated glycosides of 4β-triazolopodophyllotoxin derivatives.

Authors:  Cheng-Ting Zi; Zhen-Hua Liu; Gen-Tao Li; Yan Li; Jun Zhou; Zhong-Tao Ding; Jiang-Miao Hu; Zi-Hua Jiang
Journal:  Molecules       Date:  2015-02-16       Impact factor: 4.411

3.  Design, synthesis and cytotoxic activity of novel sulfonylurea derivatives of podophyllotoxin.

Authors:  Zhi-Jun Zhang; Jing Tian; Li-Ting Wang; Mei-Juan Wang; Xiang Nan; Liu Yang; Ying-Qian Liu; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Bioorg Med Chem       Date:  2013-11-28       Impact factor: 3.641

4.  Synthesis and antitumor activity of novel aroylthiourea derivatives of podophyllotoxin.

Authors:  Yu Zhao; Chengniu Wang; Zhonghua Wu; Jinghuai Fang; Li Zhu
Journal:  Invest New Drugs       Date:  2010-08-10       Impact factor: 3.850

5.  Antitumor agents. 125. New 4 beta-benzoylamino derivatives of 4'-O-demethyl-4-desoxypodophyllotoxin and 4 beta-benzoyl derivatives of 4'-O-demethylpodophyllotoxin as potent inhibitors of human DNA topoisomerase II.

Authors:  X M Zhou; Z Q Wang; H X Chen; Y C Cheng; K H Lee
Journal:  Pharm Res       Date:  1993-02       Impact factor: 4.200

6.  Structure-based design, synthesis and biological testing of etoposide analog epipodophyllotoxin-N-mustard hybrid compounds designed to covalently bind to topoisomerase II and DNA.

Authors:  Arun A Yadav; Xing Wu; Daywin Patel; Jack C Yalowich; Brian B Hasinoff
Journal:  Bioorg Med Chem       Date:  2014-09-16       Impact factor: 3.641

Review 7.  Recent progress on C-4-modified podophyllotoxin analogs as potent antitumor agents.

Authors:  Ying-Qian Liu; Jing Tian; Keduo Qian; Xiao-Bo Zhao; Susan L Morris-Natschke; Liu Yang; Xiang Nan; Xuan Tian; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2014-05-14       Impact factor: 12.944

8.  4-Des-oxy-4β-[(5-meth-oxy-1H-indol-3-yl)oxalylamino]podophyllotoxin methanol solvate.

Authors:  Min Feng; Ming Zhao; Jingze Zhang; Zaixin Yang; Hong Chen
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2008-11-13

9.  Synthesis and Anticancer Activity of 4β-Triazole-podophyllotoxin Glycosides.

Authors:  Cheng-Ting Zi; Gen-Tao Li; Yan Li; Jun Zhou; Zhong-Tao Ding; Zi-Hua Jiang; Jiang-Miao Hu
Journal:  Nat Prod Bioprospect       Date:  2015-04-14

10.  Novel DNA topoisomerase IIα inhibitors from combined ligand- and structure-based virtual screening.

Authors:  Malgorzata N Drwal; Jessica Marinello; Stefano G Manzo; Laurence P G Wakelin; Giovanni Capranico; Renate Griffith
Journal:  PLoS One       Date:  2014-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.